Remove companies thermo-fisher-scientific-inc
article thumbnail

Why Proteomics Solutions Provider Olink's Shares Are Rocketing Today

Benzinga

Olink Holding AB (NASDAQ: OLK ) shares are trading higher by over 65% after Thermo Fisher Scientific Inc (NYSE: TMO ) announced a deal to acquire the company for about $3.1 billion, including net cash of around $143 million. As per the terms, TMO will acquire OLK for $26.00

Equity 52
article thumbnail

Thermo Fisher Acquires Audax-Backed CorEvitas For Over $900M

Benzinga

Thermo Fisher Scientific Inc (NYSE: TMO ) agreed to acquire CorEvitas LLC from Audax Private Equity for $912.5 provides regulatory-grade, real-world evidence solutions to pharmaceutical and biotechnology companies with objective data and clinical insights to improve patient care and outcomes. million in cash.

Equity 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Thermo Fisher Buys Diagnostic Products Firm In $2.6B Deal

Law 360 M&A

Thermo Fisher Scientific Inc. billion), the companies announced Monday in separate statements. will purchase The Binding Site Group, a specialty diagnostic products firm, from a shareholder group led by European private equity firm Nordic Capital, in an all-cash deal valued at £2.25 billion ($2.58

article thumbnail

Europe CRO Services Market Size [2022-2029] worth USD 35.91 Billion | exhibiting a CAGR of 9.0%

Benzinga

December 2021: Thermo Fisher Scientific Inc. This attainment boosted the prime facilities and services of the company. This is likely to bolster the Europe CRO services market share value. Key Industry Development. finalized the procurement of Pharmaceutical Product Development, LLC.

article thumbnail

Toothbrush Market to Hit USD 9.14 Billion by 2029 | Launch of Innovative Products and Prevalence of Oral Disorders to Fuel Market Growth

Benzinga

Fortune Business Insights™ lists out all the toothbrush market companies that are presently striving to reduce the impact of the Covid-19 pandemic on the market: Hoffmann-La Roche Ltd (Basel, Switzerland). Thermo Fisher Scientific, Inc. Beckman Coulter, Inc. Tulip Diagnostics (P) Ltd (PerkinElmer Inc.)